HEART VALVE DISEASES

This study tests a new device called the Edwards EVOQUE system to replace the tricuspid valve in people with severe leakage. The goal is to see if it safely reduces leakage and improves symptoms like shortness of breath and fatigue. About 864 adults with severe tricuspid regurgit…

This study tests a new heart valve device (Navitor TAVI) for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. It includes 1,500 participants who are at low or intermediate risk for surgery. The goal is to see if the device is safe and e…

This study tested a new device called the Tendyne Transcatheter Mitral Valve System to treat people with a severe leaky heart valve (mitral regurgitation). About 103 participants received either the Tendyne device or another approved device. The goal was to see if the new valve i…

This study is testing a new device called the EVOQUE system to replace a leaky tricuspid valve without open-heart surgery. The goal is to see if it is safe and works well for people with moderate to severe valve leakage who still have symptoms despite medication. About 228 partic…

This study looks at whether it is safe for people with narrowed heart valves to be discharged just 24 hours after a minimally invasive valve replacement (TAVI). Researchers will track 585 patients for complications like stroke, heart attack, or need for a pacemaker. The goal is t…